A new approach to the quantitative measurement of dense LDL subfractions

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 14, Issue 2, 2004, Pages 73-80

  Berg, G ^a   Muzzio, M L ^a   Wikinski, R ^a   Schreier, L ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

LDL composition; LDL subclasses; Lipoproteins; Small dense LDLs; Ultracentrifugation

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; FRACTIONATION; GEL ELECTROPHORESIS; HUMAN; PLASMA; POSTMENOPAUSE; QUANTITATIVE ANALYSIS; ROC CURVE; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

EID: 3042590120     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-4753(04)80013-9     Document Type: Article

References (42)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 285: 2486-2497
2. Krauss RM, Burke DJ (1982) Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23: 97-104
3. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921
4. Kwiterovich PO (1988) HyperapoB: a pleiotropic phenotype characterized by dense low density lipoproteins and associated with coronary artery disease. Clin Chem 34/8: B71-B77
5. Krauss RM (1987) Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease Am Heart J 113: 578-582
6. Austin MA, King MC, Vranizan KM, Krauss RM (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82: 495-506
7. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106: 241-253
8. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW, Schaefer EJ (1992) Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12: 187-195
9. Kwiterovich PO (2002) Clinical relevance of the biochemical, metabolic and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol 90: 30i-47i
10. Siegel RD, Cupples A, Schaefer EJ, Wilson PWF (1996) Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham Offspring Study. Metabolism 45: 1267-1272
11. Carr MC, Kim KH, Zambon A, Mitchell ES, Woods NF, Casazza CP, Purnell JQ, Hokanson JE, Brunzell JD, Schwartz RS (2000) Changes in LDL density across the menopausal transition. J Invest Med 48: 245-250
12. Alabakovska S, Todorova B, Labudovic D, Toshedska K (2002) LDL and HDL subclass distribution in patients with end-stage renal diseases. Clin Biochem 35: 211-226
13. Sniderman AD (2002) How and when to use apoB in clinical practice. Am J Cardiol 90: 48i-54i
14. Furuya D, Yagihashi A, Nasu S, Endoh T, Nakamura T, Kaneko R, Kamagata C, Kobayashi D, Watanabe N (2000) LDL particle size by gradient-gel electrophoresis cannot be estimated by LDL-cholesterol/apolipoprotein B ratios. Clin Chem 48: 1202-1203
15. Austin MA, Hokanson JE, Brunzell JD (1994) Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 5: 395-403
16. Kulkarni KR, Garber DW, Jones MK, Segrest JP (1995) Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology. J Lipid Res 36: 2291-2302
17. Swinkels DW, Hak-Lemmers HLM, Demacker PNM (1987) Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res 28: 1233-1239
18. Zambon A, Austin MA, Brown GB, Hokanson JE, Brunzell JD (1993) Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 13: 147-153
19. Nichols AV, Krauss RM, Musliner TA (1986) Nondenaturing polyacrylamide gradient gel electrophoresis. In: Colowick S, Kaplan N (eds) Methods in Enzymology. Academic Press, vol 128, pp 417-431
20. Noble RP (1960) Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 9: 693-700
21. Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234: 466-468
22. Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275
23. Tornvall P, Karpe F, Carlson LA, Hamsten A (1991) Relationship of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 90: 67-80
24. Lamarche B, Lemieux I, Després JP (1999) The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab 25: 199-211
25. Chapman MJ, Guerin M, Bruckert E (1998) Atherogenic, low-density lipoproteins. Pathophysiology and new therapeutic approaches. Eur Heart J 19 (suppl A): A24-A30
26. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd PJ (1996) Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 124: 261-271
27. Schreier L, Sanguinetti S, Mosso H, Lopez G, Siri L, Wikinski R (1996) Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease. Clin Biochem 29: 479-487
28. Shen MMS, Krauss RM, Lindgren FT, Forte TM (1981) Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res. 22: 236-244
29. Rainwater DL, Ludwig MJ, Haffner SM, Van de Berg JL (1995) Lipid and lipoprotein factors associated with variation in Lp(a) density. Arterioscler Thromb Vasc Biol 15: 313-319
30. Seman LJ, DeLuca C, Jenner JL, Cupples LA, McNamara JR, Wilson PW, Castelli WP, Ordovas JM, Schaefer EJ (1999) Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem 45: 1039-1046.
31. Menys VC, Liu Y, Mackness MI, Caslake MJ, Kwok S, Durrington PN (2003) Measurement of plasma small-dense LDL concentration by a simplified ultracentriguation procedure and immunoassay of apolipoprotein B. Clin Chim Acta 334: 95-106
32. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP (1997) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation 95: 69-75
33. St-Pierre A, Ruel I, Cantin B, Dagenais G, Bernard P-M, Després J-P, Lamarche B (2001) Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104: 2295-2299
34. Otvos JD, Jeyarajah EJ, Cromwell WC (2002) Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 90: 22i-29i.
35. Hattori Y, Suzuki M, Tsyshima M, Yoshida M, Tokunaga Y, Wang Y, Zhao D, Takeuchi M, Hara Y, Ryomoto KI, Ikebuchi M, Kishioka H, Mannami T, Baba S, Harano Y (1998) Development of approximate formula for LDL-cholesterol, LDL-apoB and LDL-cholesterol/LDL-apoB as indices of hyperapobetalipoproteinemia and small dense LDL. Atherosclerosis 138: 289-299
36. Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Despres JP (1996) The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity and hyperinsulinemia in men. Diabetes Care 19: 629-637
37. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM (1993) Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92: 141-145
38. Packard C, Shepherd J (1997) Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17: 3542-3556
39. Laasko M, Sarlund H, Ehnholm C, Voutilainen E. Aro A, Pyörälä K (1987) Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes. Diabetologia 30: 703-706
40. Baynes C, Henderson AD, Anyaoku W, Richmond W, Hughes CL, Johnston DG, Elkeles RS (1991) The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med 8: 560-566
41. Berg G, Siseles N, Gonzalez A, Contreras Ortiz O, Tempone A, Wikinski R (2001) Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause 8: 51-57
42. Sniderman A, Scantlebury T, Cianflone K (2001) Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 135: 447-459